Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

by Chan A.T.C.
Published 2023

Equitable risks allocation of projects inside China: Analyses from Delphi survey studies

by Ke, Y., Wang, S., Chan, A.P.C.
Published 2013

Risk allocation in public-private partnership infrastructure projects: Comparative study

by Ke, Y., Wang, S., Chan, A.P.C.
Published 2013

Risk management practice in China's Public-Private Partnership projects

by Ke, Y., Wang, S., Chan, A.P.C.
Published 2013

A comparative study of critical success factors for public private partnerships (PPP) between Mainland China and the Hong Kong Special Administrative Region

by Cheung, E., Chan, A.P.C., Lam, P.T.I., Chan, D.W.M., Ke, Y.
Published 2014

A computerized risk evaluation model for public-private partnership (PPP) projects and its application

by Xu Y., Lu Y., Chan A.P.C., Skibniewski M.J., Yeung J.F.Y.
Published 2018

Empirical study of risk assessment and allocation of public-private partnership projects in China

by Chan, A.P.C., Yeung, J.F.Y., Yu, C.C.P., Wang, S.Q., Ke, Y.
Published 2013

Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation

by Ying, J., Li, H., Chan, A.T.C., Tao, Q., Seng, T.J., Langford, C., Srivastava, G., Tsao, S.W., Putti, T., Murray, P.
Published 2012

Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation

by Ying, J., Li, H., Seng, T.J., Langford, C., Srivastava, G., Tsao, S.W., Putti, T., Murray, P., Chan, A.T.C., Tao, Q.
Published 2016

Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: A multicenter phase II study by the cancer therapeuti...

by Ho, W.M., Ma, B., Mok, T., Yeo, W., Lai, P., Lim, R., Koh, J., Wong, Y.Y., King, A., Leow, C.K., Chan, A.T.C.
Published 2016

A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic eva...

by Ma, B., Lam, K.C., Mo, F., Chan, A.T.C., Zee, B., Mok, T., Goh, B.C., Soo, R., Wang, L.Z., Tan, E.H., Leong, S.S.
Published 2011

A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic eva...

by Ma, B., Goh, B.C., Tan, E.H., Lam, K.C., Soo, R., Leong, S.S., Wang, L.Z., Mo, F., Chan, A.T.C., Zee, B., Mok, T.
Published 2014

Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: A multicentre immunohistochemical study in the Asia-Pacific region

by Putti, T.C., Lee, Y.S., To, K.F., Tse, G., Chan, A.T.C., Hsu, H.C., Lai, G.M., Whang-Peng, J., Millward, M., Lee, C.S., Lin, L., Lin, X.
Published 2012

A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors

by Low, J.S.W., Tao, Q., Ng, K.M., Goh, H.K., Shu, X.-S., Woo, W.L., Ambinder, R.F., Srivastava, G., Shamay, M., Chan, A.T.C., Popescu, N.C., Hsieh, W.-S.
Published 2014

Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas

by Jin, H., Wang, X., Ying, J., Wong, A.H.Y., Li, H., Lee, K.Y., Chan, A.T.C., Yeo, W., Ma, B.B.Y., Tao, Q., Srivastava, G., Putti, T.C., Lung, M.L., Shen, Z.-Y., Xu, L.-Y., Langford, C.
Published 2012

Irofulven as first line therapy in recurrent or metastatic gastric cancer: A phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)

by Yeo, W., Zee, B., Ma, B., Lam, K.C., Mo, F.K.F., Ng, E.K.W., Ho, R., Chan, A.T.C., Yeo, W., Boyer, M., Clarke, S., Beale, P., Chung, H.C., Roh, J.K., Rha, S.Y., Jeung, H.C., Ong, S.Y.K., Lim, R., Soo, R., Goh, B.C.
Published 2011

Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors fr...

by Yeo, W., Chung, H.C., Chan, S.L., Wang, L.Z., Lim, R., Picus, J., Boyer, M., Mo, F.K.F., Koh, J., Rha, S.Y., Hui, E.P., Jeung, H.C., Roh, J.K., Yu, S.C.H., To, K.F., Tao, Q., Ma, B.B., Chan, A.W.H., Tong, J.H.M., Erlichman, C., Chan, A.T.C., Goh, B.C.
Published 2014